Recurrent melioidosis in the darwin prospective melioidosis study: Improving therapies mean that relapse cases are now rare

Abstract

The Darwin Prospective Melioidosis Study has documented 785 melioidosis cases over 23 years. Recurrent melioidosis occurred in 39/679 (5.7%) patients surviving initial infection; 29 patients suffered relapse of the original infection, and 10 presented with a new Burkholderia pseudomallei infection. With improved therapy, relapse has become rare in recent years. Copyright © 2014, American Society for Microbiology. All Rights Reserved.